Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS)

CUSIP: N69605108

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / Ordinary Shares, Euro 0.12 par value per share
Shares outstanding
65,632,680
Total 13F shares
21,301,855
Share change
-1,013,099
Total reported value
$239,644,411
Price per share
$11.25
Number of holders
25
Value change
-$1,830,525
Number of buys
14
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP N69605108?
CUSIP N69605108 identifies PHVS - Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS) as of Q4 2022

As of 31 Dec 2022, Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,301,855 shares. The largest 10 holders included FMR LLC, Foresite Capital Management IV, LLC, VIKING GLOBAL INVESTORS LP, Bain Capital Life Sciences Investors, LLC, GENERAL ATLANTIC, L.P., venBio Partners LLC, Novo Holdings A/S, Cormorant Asset Management, LP, 5AM Venture Management, LLC, and Soleus Capital Management, L.P.. This page lists 25 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.